通过针对性预防预测严重血友病A的关节参与,这是可能的吗?
Maria Del Mar Meijon-Ortigueira1, Maria Teresa Alvarez-Roman2, Hortensia De La Corte3
1Department of Hematology, Ramon y Cajal Hospital-IRYCIS, Madrid, Spain.
概括
在21个月之前早期开始预防对于预防严重血友病A患者的关节问题至关重要. 这一发现支持个性化治疗策略,以获得更好的血友病护理结果.
科学领域:
- 血液学 血液学 血液学
- 儿科医学 儿科医学
- 整形外科 整形外科 整形外科
背景情况:
- 量身定制的预防是严重血友病A的标准.
- 目前的指导方针提供了两种方法:临床特征或药理动力学参数.
- 优化治疗需要整合这些方法.
研究的目的:
- 提出一个整合预防特征的模型,以优化治疗.
- 确定影响严重血友病A患者关节状况的关键因素.
主要方法:
- 分析预防开始时的年龄,出血事件,坚持,FVIII最低水平和关节状况.
- 这项研究包括59名20年来严重的血友病A型患者.
主要成果:
- 83%的患者没有关节干扰;年平均出血率 (ABR) 为0.7.7.
- 在21个月之前开始的预防是预防关节干扰的重要保护因素 (OR 88.33,p=0.031).
- 观察到高坚持 (>85%) 和体力活动 (72.9%).
结论:
- 早期预防 (21个月前) 是保持关节健康的最关键因素.
- 需要对综合模型进行进一步的研究,以个性化血友病A治疗.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Disorders of Hemostasis
885
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
885
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Extrinsic and Intrinsic Pathways of Hemostasis
7.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.5K


